1028 Preoperative Steroid Use Effects on Outcomes Following Surgery for Spine Metastatic Tumors

View at publisher Summarise with VIRAT
Authors: Michael Melhem, Khaled M. Taghlabi, Paul Nemer, Justin B. Chen, Amir Hossein Faraji
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Preoperative steroids are known to poorly affect outcomes following surgery. Many cancer types can metastasize to the spine, requiring surgical removal. The relationship between preoperative steroid use and outcomes of surgery for spinal metastatic tumors has not been recently studied. METHODS: The 2007-2021 American College of Surgeons – National Surgical Quality Improvement Program (ACS-NSQIP) dataset was queried for patients who were taking steroids prior to surgery for spinal metastatic tumors yielding 3120 patients. Outcomes assessed included surgical site infection, pneumonia, reintubation, wound dehiscence, pulmonary embolism, stroke, MI, ventilator use, sepsis rate, and 30-morbidity and mortality. Chi-squared, t-test, and logistic regression were used to analyze the effect on preoperative steroid use on outcomes of these surgeries. RESULTS: The steroid use and non-steroid use groups did not differ in age, operative time, length of stay, or age. Preoperative steroid use was associated with pneumonia (6% vs 4.1%, p = 0.049), failure to wean off ventilator (3.4% vs 1.6%, p = 0.005), increased rate of septic shock (2.2% vs 0.8%, p = 0.006), and increased 30-day mortality (8.9% vs 6.2%, p = 0.029). On multivariate logistic regression, steroids were correlated with increased 30-day mortality (OR 1.62, CI: 1.06, 2.5, p = 0.026). CONCLUSIONS: Preoperative steroid use was associated with greater risk of pneumonia, failure to wean ventilator, increased rate of septic shock, and higher 30-day mortality following surgery for metastatic spine tumors. These risks must be considered when medically managing patients following these surgeries.

Fields of Study & Subjects

Management of metastatic bone disease Cancer Stress Anesthesia and Immune Response Infectious Diseases and Tuberculosis

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
181–182
Publication date
26 March 2026
Language
EN